FIELD: medicine, pharmacy. SUBSTANCE: an aqueous suspension has microcrystals of water-insoluble drug at solid state (diameter is 0.05-10 mcm) at amount 0.01-40 wt. -%/vol. Microcrystals are covered with the capsulating primary layer of lipid (thickness is 0.3-3 mcm). By the second variant microcrystals are covered with capsulating primary layer of lipid consisting of covering and enveloping layers and the following secondary layer (thickness is 25 nm-3 mcm) consisting of the indicated lipid in form of vesicles associated with microcrystals of drug surrounding their and distributed in suspending medium. Mass ratio of drug to lipid = (1:1)-(1000:1). Membrane-forming amphipatic lipid is phospholipid. Suspension is used for administration of high concentration of water-insoluble drug. EFFECT: improved property of suspension. 15 cl, 9 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
SURGICAL IMPLANT MATERIAL OR BANDAGE MATERIAL RELEASING MEDICATION PREPARATION | 1995 |
|
RU2176525C2 |
DISPERSABLE MICROPARTICLES STABILIZED WITH PHOSPHOLIPID | 1999 |
|
RU2233654C2 |
AQUEOUS AEROSOL PREPARATION | 2004 |
|
RU2363449C2 |
PARENTERAL FORMULATIONS OF ELACYTARABINE DERIVATIVES | 2011 |
|
RU2571283C2 |
COMPOSITION OF AN AQUEOUS SUSPENSION COMPRISING NANOPARTICLES OF MACROLIDE ANTIBIOTICS | 2014 |
|
RU2707748C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INTERSTITIAL CYSTITIS | 2002 |
|
RU2290929C2 |
BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL APPLICATION FOR INCREASE OF DRUG ACTIVITY AND DECREASE OF SIDE EFFECTS | 2010 |
|
RU2469706C2 |
AQUEOUS SUSPENSION CONTAINING GLUCOCORTICOSTEROID NANOPARTICLES | 2016 |
|
RU2747803C2 |
PHARMACEUTICAL COMPOSITION OF INDOMETACIN INCLUDED IN PHOSPHOLIPID NANOPARTICLES FOR TREATING RHEUMATIC AND INFLAMMATORY DISEASES | 2009 |
|
RU2417079C1 |
Authors
Dates
1997-12-27—Published
1992-10-23—Filed